CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Gross Block History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Gross Block | ₹23,825 Cr | ₹19,656 Cr | ₹18,161 Cr | ₹17,205 Cr | ₹16,968 Cr |
What is the latest Gross Block ratio of CIPLA ?
| Year | Gross Block |
|---|---|
| Mar2026 | ₹23,825 Cr |
| Mar2025 | ₹19,656 Cr |
| Mar2024 | ₹18,161 Cr |
| Mar2023 | ₹17,205 Cr |
| Mar2022 | ₹16,968 Cr |
How is Gross Block of CIPLA Trending?
| Years | Gross Block | % Change | |
|---|---|---|---|
| Mar2026 | ₹23,825 Cr | 21.21 | |
| Mar2025 | ₹19,656 Cr | 8.23 | |
| Mar2024 | ₹18,161 Cr | 5.56 | |
| Mar2023 | ₹17,205 Cr | 1.39 | |
| Mar2022 | ₹16,968 Cr | - | |
Compare Gross Block of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹111,490.2 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| MANKIND PHARMA | ₹102,797.0 Cr | 8.1% | -2.2% | 1.2% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 2% |
-0.2% |
-14.3% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses